Adaptimmune

  • Home
  • Our Company
    • Overview arrow_forward
    • Board of Directors arrow_forward
    • Leadership Team arrow_forward
  • Products
  • Pipeline
    • Overview arrow_forward
    • Afami-cel arrow_forward
    • Lete-cel arrow_forward
    • Uza-cel arrow_forward
  • Technology
    • Overview arrow_forward
    • Manufacturing arrow_forward
    • Publications arrow_forward
  • Patients & Families
    • Overview arrow_forward
    • Taking Part in Our Clinical Trials arrow_forward
    • Videos arrow_forward
  • Clinical Trials
    • Overview arrow_forward
    • Expanded Access Policy arrow_forward
  • Investors & Media
    • Overview arrow_forward
    • News Center arrow_forward
    • Financial Info and Governance arrow_forward
    • Stock Data arrow_forward
    • SEC Filings arrow_forward
  • Contact
  • Careers
    • Overview arrow_forward
    • US Careers arrow_forward
    • UK Careers arrow_forward

Press Releases

Investors & Media

Investors & Media

  • Overview
  • News Center
    • Media Resources
    • Corporate Presentations
    • Press Releases
    • Publications
    • Events
    • Email Alerts
  • Financial Info and Governance
    • General Meeting (merger)
    • Company Information
    • Leadership Team
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Annual Shareholder Meeting
    • FAQ
    • Contacts
    • Adaptimmune Ltd Report
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • News Center

  • Media Resources
  • Corporate Presentations
  • Press Releases
  • Publications
  • Events
  • Email Alerts
May 10, 2017 7:30am EDT

Adaptimmune Reports First Quarter 2017 Financial Results

May 03, 2017 4:01pm EDT

Adaptimmune to Report First Quarter 2017 Financial Results on May 10, 2017

May 02, 2017 11:00am EDT

Adaptimmune to Present at Upcoming Deutsche Bank 42nd Annual Health Care Conference

Apr 10, 2017 1:32pm EDT

Adaptimmune Therapeutics plc Announces Closing of $42 Million Registered Direct Offering

Apr 05, 2017 8:33am EDT

Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares

Mar 27, 2017 4:34pm EDT

Adaptimmune to Participate in Upcoming Jefferies Immuno-Oncology Summit

Mar 27, 2017 11:26am EDT

Adaptimmune Therapeutics plc Announces Closing of Public Offering and Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares

Mar 22, 2017 9:51am EDT

Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares

Mar 21, 2017 4:55pm EDT

Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares

Mar 15, 2017 7:30am EDT

Adaptimmune Broadens Executive Team

RSS
  • Prev
  • 1...
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • ...29
  • Next
Adaptimmune
Disclosures Privacy Policy Disclaimer Search Sitemap Terms of Use Supply Terms Cookie Policy Manage Cookie Preferences
Linedin Twitter Youtube
© 2025 Adaptimmune. All Rights Reserved.